Jones Aranthan II
- SEC CIK
- 0001785894
No open-market purchases or sales filed in the past year.
Current role at each company
- VNDA Vanda Pharmaceuticals Inc.Chief Corp. Affairs Officeras of Sep 17, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Jones Aranthan II as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 17, 2021 (view filing) | Sep 15 | 2 days | Jones Aranthan IIChief Corp. Affairs Officer | SSale | −16.8K | $16.49 | −$277.4K | −17.0%82.0K after | |
| Jul 27, 2021 (view filing) | Jul 26 | 1 day | Jones Aranthan IIChief Corp. Affairs Officer | SSale | −7.25K | $19.69 | −$142.8K | −7.7%86.7K after |